Relay Therapeutics, Inc. (RLAY)

CIK 1812364 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Relay Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 202640001193125-26-386473
Sep 9, 202640001193125-26-386455
Sep 9, 202640001193125-26-386464
Aug 28, 202640001493152-26-040513
Aug 28, 202640001193125-26-374645
Aug 26, 20261440001950047-26-008711
Aug 25, 20261440001493152-26-040137
Aug 18, 202640001193125-26-355502
Aug 18, 202640001193125-26-355493
Aug 14, 2026SCHEDULE 13G/A0001831942-26-000036
Aug 10, 2026SCHEDULE 13G/A0001193125-26-342308
Aug 7, 2026SCHEDULE 13G/A0000315066-26-002255
Aug 6, 202610-Q0001193125-26-338056
Aug 6, 20268-K0001193125-26-338013
Aug 6, 2026424B50001193125-26-338292
Aug 6, 2026SCHEDULE 13G0000315066-26-002113
Aug 4, 20261440001950047-26-007601
Jul 31, 20261440001950047-26-007457
Jul 30, 202640001193125-26-326144
Jul 30, 202640001193125-26-326137
Jul 30, 202640001193125-26-326142
Jul 21, 20261440001950047-26-007243
Jul 20, 20261440001950047-26-007212
Jul 8, 202640001193125-26-298688
Jul 8, 202640001193125-26-298681